Densely Stacked CoCu-MOFs Coated with CuAl/LDH Enhance Sulfamethoxazole Degradation in PMS-Activated Systems

Xin Zhong1, Xiaojun Liu2, Meihuan Ji1

  • 1Experimental Education Platform, Beijing Normal University at Zhuhai, Zhuhai 519087, China.

Insights

This study developed a novel catalyst for advanced oxidation processes, effectively degrading refractory antibiotics like sulfamethoxazole (SMX) using potassium peroxymonosulfate (PMS) activation for cleaner wastewater management.

Area of Science:

  • Environmental Chemistry
  • Materials Science

Background:

  • Sulfate radical-based advanced oxidation processes (SR-AOPs) are promising for refractory antibiotic degradation in wastewater.
  • Systematic studies on potassium peroxymonosulfate (PMS) activation by MOF-derived metal oxides coated with layered double hydroxide (LDH) materials are limited.

Purpose of the Study:

  • To synthesize and evaluate CoCu-MOFs coated with CuAl/LDH as catalysts for PMS activation.
  • To investigate the removal efficiency and stability of the catalyst in degrading sulfamethoxazole (SMX).
  • To elucidate the reaction mechanism and identify reactive species involved in SMX degradation.

Main Methods:

  • Synthesis of CoCu-MOFs coated with CuAl/LDH.
  • PMS activation for SMX degradation.
  • Analysis of catalyst stability and metal leaching using ICP.
  • Identification of reactive species (sulfate radicals, hydroxyl radicals, 1O2) and intermediates (LC/MS).
  • XPS analysis to understand the catalyst's electronic structure and metal ion cycling.

Main Results:

  • The CoCu/LDH catalyst achieved nearly 100% SMX removal and 53.7% mineralization within 60 minutes.
  • The catalyst exhibited excellent stability with low metal leaching (Co: 0.013 mg/L, Cu: 0.313 mg/L).
  • Sulfate radicals, hydroxyl radicals, and 1O2 were identified as key reactive species, indicating coupled radical and non-radical pathways.

Conclusions:

  • The CoCu/LDH catalyst demonstrates high efficiency and stability for PMS activation in SMX removal.
  • The layered structure facilitates metal ion cycling, promoting heterogeneous PMS activation.
  • This work provides mechanistic insights into PMS activation catalysts for practical wastewater treatment applications.

Related Concept Videos

Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.5K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids01:19

Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
141